trial · primary record
Zanidatamab
HER2-positive Breast Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 125 |
| Primary completion | 2030-05-02 |
| Primary endpoint | Number of participants with pCR |
| Registry ID | NCT07102381 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:34:30.263Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07102381
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Zanidatamab · compound